0000950123-23-001984.txt : 20230213
0000950123-23-001984.hdr.sgml : 20230213
20230213161020
ACCESSION NUMBER: 0000950123-23-001984
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20221231
FILED AS OF DATE: 20230213
DATE AS OF CHANGE: 20230213
EFFECTIVENESS DATE: 20230213
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Column Group LLC
CENTRAL INDEX KEY: 0001833486
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-20797
FILM NUMBER: 23618489
BUSINESS ADDRESS:
STREET 1: 1 LETTERMAN DRIVE, BUILDING D
STREET 2: SUITE M-900
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94129
BUSINESS PHONE: 415-865-2050
MAIL ADDRESS:
STREET 1: 1 LETTERMAN DRIVE, BUILDING D
STREET 2: SUITE M-900
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94129
13F-HR
1
primary_doc.xml
X0202
13F-HR
LIVE
0001833486
XXXXXXXX
12-31-2022
12-31-2022
false
Column Group LLC
1 Letterman Drive, Building D
Suite M-900
San Francisco
CA
94129
13F HOLDINGS REPORT
028-20797
N
James Evangelista
Chief Financial Officer
(415) 865-2050
/s/ James Evangelista
San Francisco
CA
02-13-2023
0
7
300399162
false
INFORMATION TABLE
2
20415.xml
INFORMATION TABLE FOR FORM 13F
eFFECTOR Therapeutics Inc
COM
28202V108
1842669
4309329
SH
SOLE
4309329
0
0
NGM Biopharmaceuticals Inc
COM
62921N105
91046410
18136735
SH
SOLE
18136735
0
0
ORIC Pharmaceuticals Inc.
COM
68622P109
21016586
3568181
SH
SOLE
3568181
0
0
RAPT Therapeutics Inc
COM
75382E109
53076296
2680621
SH
SOLE
2680621
0
0
Revolution Medicines Inc
COM
76155X100
109044149
4577840
SH
SOLE
4577840
0
0
Surrozen, Inc.
COM
86889P109
5478469
9414795
SH
SOLE
9414795
0
0
Tenaya Therapeutics, Inc.
COM
87990A106
18894583
9400290
SH
SOLE
9400290
0
0